CurrentEndo
Get Weekly

Topic · page 6 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 201–240 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. Osteoporos Int

    Secondary fracture risk after hip fracture in older patients: an updated sex-specific systematic review and meta analysis with GRADE and PAF assessment

    Meta-analysis

  2. Osteoporos Int

    Romosozumab is effective in patients with variants in LRP5, LRP6, or WNT1

    Cohort study

  3. Osteoporos Int

    Clinical implementation of AI for vertebral fracture detection in CT aligned with fracture liaison services: high prevalence of undiagnosed vertebral fractures

    Cohort study

  4. Osteoporos Int

    Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis

    Meta-analysis

  5. Osteoporos Int

    Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss

    Cohort study

  6. Osteoporos Int

    A meta-analysis of smoking and fracture risk to update the FRAX® tool

    Meta-analysis

  7. J Clin Endocrinol Metab

    Timeliness of antiresorptive consolidation after anabolic therapy for primary fracture prevention: A US cohort study

    Cohort study

  8. JAMA Netw Open

    Use and Implications of the Fracture Risk Assessment Tool in Primary Hyperparathyroidism

    Cohort study

  9. Clin Endocrinol (Oxf)

    Nailfold Capillary Changes in Primary Hyperparathyroidism

    Cross-sectional study

  10. J Clin Endocrinol Metab

    Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences

    Cross-sectional study

  11. Osteoporos Int

    The impact of Tai Chi on osteoporosis and osteopenia in middle-aged and elderly adults: a systematic review and meta-analysis of randomized controlled trial

    Meta-analysis

  12. J Clin Endocrinol Metab

    High normal parathyroid hormone and cardiovascular and total mortality: sex and age disparities in the ELSA-Brasil study

    Cohort study

  13. Osteoporos Int

    Clinical utility of one-third radius BMD in a population-based prospective cohort of older adults: Insights from the São Paulo Aging & Health (SPAH) study

    Cohort study

  14. Osteoporos Int

    Incidence of proximal humerus fracture among older adults in Oslo, Norway varies by country background, marital status, and season

    Cohort study

  15. Osteoporos Int

    Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson’s disease

    Cohort study

  16. Eur J Endocrinol

    Combined effect of MASLD and low muscle strength on the risk of osteoporotic fractures: A UK Biobank cohort study

    Cohort study

  17. J Bone Miner Res

    Mortality following atypical femoral fractures in men

    Cohort study

  18. Osteoporos Int

    Exercise improves quality of life, mental health and pain in people living with osteoporosis: a systematic review and meta-analysis

    Meta-analysis

  19. Osteoporos Int

    Trends of clinical vertebral and hip fractures following local government involvement in fracture prevention from 2015 to 2021 in Kure, Japan

    Cohort study

  20. Eur J Endocrinol

    Determinants of extracellular fluid calcium concentration in patients with chronic hypoparathyroidism

    Cohort study

  21. J Bone Miner Res

    Performance of U.S.-FRAX by race and ethnicity for short-term hip and major osteoporotic fracture prediction in U.S. women with rheumatoid arthritis

    Cohort study

  22. Osteoporos Int

    The recurrence of osteoporotic fractures among first- and second-generation immigrants in Sweden

    Cohort study

  23. Obesity (Silver Spring)

    Bone Health After Metabolic and Bariatric Surgery: Osteometabolism Biomarkers, Bone Mineral Density, and Microarchitecture

    Cross-sectional study

  24. Osteoporos Int

    Balancing risks in febrile hip fracture patients: is surgical delay more dangerous than infection?

    Cohort study

  25. Osteoporos Int

    External validation of the proposed diagnostic criteria for hypophosphatasia in adults of a Spanish cohort

    Diagnostic or prognostic study

  26. Osteoporos Int

    Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study

    Cohort study

  27. Osteoporos Int

    Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis

    Meta-analysis

  28. Osteoporos Int

    “Build better bones”: development, launch, and future directions of a multilingual, user-centered website for osteoporosis management

    Research article

  29. J Clin Endocrinol Metab

    Health and adverse events associated with extended oral bisphosphonates among postmenopausal women: a systematic review

    Meta-analysis

  30. J Bone Miner Res

    Impact of current and previous smoking on fracture risk in older women: the role of physical function, bone density, and bone microarchitecture

    Cohort study

  31. J Clin Endocrinol Metab

    Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures

    Cohort study

  32. J Bone Miner Res

    The Osteoporotic Fractures in Men study (MrOS): a 25-yr landmark study of skeletal health in older men

    Cohort study

  33. J Bone Miner Res

    Leg power and velocity predict the risk of major osteoporotic fractures (MOF): the Osteoporotic Fractures in Men (MrOS) study

    Cohort study

  34. J Bone Miner Res

    Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial

    Research article

  35. Endocr Pract

    Denosumab Therapy Beyond 10 Years: Subsequent Treatment and Densitometric Outcomes

    Cohort study

  36. J Bone Miner Res

    Longitudinal comparison of bone, growth, and biochemical markers in breastfed HIV-exposed uninfected and HIV-unexposed Ugandan children

    Cohort study

  37. Osteoporos Int

    State sequence analysis for a deeper understanding of treatment adherence patterns in fragility fracture patients

    Cohort study

  38. Clin Endocrinol (Oxf)

    One Year Cholecalciferol and Calcium Supplementation Improve BMD But Not Trabecular Bone Score in Asymptomatic Hypovitaminosis D

    Cohort study

  39. Osteoporos Int

    Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohort

    Cohort study

  40. Endocr Pract

    Superior Efficacy of Denosumab Over Zoledronic Acid in Increasing Femoral Neck Bone Mineral Density in Osteoporosis Patients With Type 2 Diabetes Mellitus

    Cohort study

All 1,367 Briefs in ExploreShowing Briefs 201–240 of 1,367, newest first